About Us

Together, we can advance innovation, expand access to care and empower people to live well.

About the Foundation

Our Board

Foundation Team

Contact Us

Photo of Riggs BUMC ED exterior

Cancer care

Propel advances in cancer research and treatment, bringing hope and healing to patients.

Capital & technology

Invest in the future of healthcare by helping expand and modernize our North Texas facilities.

Community health

Expand access to compassionate healthcare for underserved individuals and families.

Graduate medical education

Shape the future of medicine by helping train the next generation of physicians.

In your region

Make a direct impact on Baylor Scott & White hospitals and patients in your community.

Patient programs

Help enhance patient well-being through innovative, patient-centered programs.

Research

Help drive discoveries and improve patient outcomes by supporting accessible research and clinical trials.

Transplant

Support life-changing care for transplant patients and their families.

Donate online

Your gift can make an immediate difference in the lives of those we serve.

Grateful Giving

Patients and loved ones can show appreciation for the caregivers who made a difference during their healthcare experience.

Make a planned gift

Learn about the multiple ways to make a planned gift and create a lasting legacy.

Giving societies

Giving societies honor donors for their generosity in empowering people to live well.

Celebrating Women

Help us advance the fight against breast cancer through Celebrating Women.

Grand Rounds

Support graduate medical education at Baylor Scott & White by participating in the Ground Rounds golf tournament.

Grand Rounds Golf Tournament logo

The Compass

Read the latest issue of The Compass, a quarterly newsletter from the Baylor Scott & White Dallas Foundation.

Texas Cancer Interception Institute

Baylor Scott & White Health is committed to revolutionizing cancer care by intercepting cancer at its earliest stages. The Texas Cancer Interception Institute (TCII) is leading the charge in early detection, prevention and research—and philanthropy plays a crucial role in making this vision a reality. 

The need for earlier cancer detection

Seventy percent of cancer-related deaths occur due to cancers that lack a recommended screening test, making early detection a critical factor in survival. Intercepting cancer in its earliest and most treatable form is essential to maximizing recovery chances for those facing this disease. 

With national efforts underway to reduce cancer mortality by 50% over the next 25 years, Baylor Scott & White is committed to advancing this mission through the Texas Cancer Interception Institute (TCII). TCII is leading the charge in shifting cancer care from a reactive model—treating cancer after symptoms appear—to a proactive, interception-based approach. By integrating patient navigation with cutting-edge innovations in genomic sequencing, biomarker research, and AI-driven diagnostics, TCII is transforming how we detect and treat cancer, improving outcomes for patients across Texas and beyond. 

Advancing early cancer interception

The landscape of cancer care is changing, with emerging methods—such as simple blood tests—showing the potential to detect cancer before symptoms develop. This shift requires bold action and investment in proactive strategies that enable earlier intervention. 

As the largest not-for-profit health system in Texas with more than 13.5 million patient encounters annually, Baylor Scott & White is uniquely positioned to lead this transformative initiative by combining our vast patient network with our leading expertise in cancer care. As a key priority initiative of Baylor Scott & White, TCII is poised to become a leader in early detection and diagnosis across Texas and beyond.  

With a lead, transformational gift from the Jeff and Carmen York Family, TCII has already begun its groundbreaking work—but continued philanthropic investment is essential to sustain and expand these efforts. 

Texas Cancer Interception Institute: Pioneering a new era of cancer care

Texas Cancer Interception Institute and Baylor Scott & White Health logo lockup

The goal of TCII is to change the conversation for the tens of thousands of people each year who will hear the dreaded words: “You have cancer.”

Approaching the fight against cancer from multiple angles, TCII unites several exciting developments in early detection under one umbrella to accelerate impact in the lives of Texans, including: 

PRE-CANCER DIAGNOSIS: How we are diagnosing earlier  

  • Multi-Cancer Early Detection (MCED): Through a partnership with Exact Sciences, 50,000 MCED blood tests are being deployed across Baylor Scott & White primary care offices. These simple blood tests can detect cancerous tumor DNA before symptoms may develop  
  • High-Risk Breast Screening Program: This initiative helps patients who are identified as high risk to begin risk-reduction and surveillance strategies to enable the earliest diagnosis of breast cancer.  
  • AI Technology: From advanced imaging interpretation to predictive analytics, AI tools will enable us to identify patients who are at high risk for cancer and allow for earlier and more effective interventions. 

POST-CANCER DIAGNOSIS: Using precision medicine to treat patients and develop population health models  

  • Texas Immuno-oncology Biorepository: This hub collects biospecimens from a diverse population across Texas to advance studies on cancer recurrence and improve immuno-therapies. Using data collected from cancer patients across the state, researchers are finding microscopic clues that signal cancer growth.  
  • Genomics: Sequencing a person’s DNA allows care teams to generate a personalized readout of what genetic alterations are happening in a patient and why. With that knowledge, that person’s cancer can be more precisely targeted with the right treatments.  
  • TRIM Trial: This is a first-of-its-kind clinical trial to investigate the use of a new weight loss drug, Zepbound®, to reduce the risk of breast cancer recurrence in patients with obesity. 

PATIENT SUPPORT: Throughout a cancer journey  

Psychological & Genetic Counseling: This provides mental health support and genetic risk assessment.

Join us in our fight to intercept cancer

Texas Cancer Interception Institute is a transformational philanthropic initiative to advance early interception and accelerate care for those facing a cancer diagnosis. Community support will continue to be vital in achieving this bold vision. Your gift will help ensure the long-term sustainability of TCII and foster continued research and innovation, redefining the future of cancer care for generations to come.

Featured stories

Learn how donors are making an impact in cancer care through the Texas Cancer Interception Institute at Baylor Scott & White.

Photograph of York family

York family turns personal journey into mission to transform cancer care

March 22, 2025
Building on this passion and gratitude, the Jeff and Carmen York Family have generously committed $7 million to help fund a new era in cancer detection, the Texas Cancer Interception Institute (TCII).
Learn More York family turns personal journey into mission to transform cancer care
headshot of Dr. Joyce O'Shaughnessy

Intercepting breast cancer recurrence – Dr. Joyce O’Shaughnessy

September 1, 2024
A groundbreaking trial: New weight-loss drugs can help keep pounds away. Can they also help keep cancer at bay? Medications such as Wegovy® and Zepbound® have revolutionized the management of being overweight or obese. Researchers are now exploring these drugs’ potential benefits for a range of other conditions—possibly even to help prevent a recurrence of […]
Learn More Intercepting breast cancer recurrence – Dr. Joyce O’Shaughnessy
Multi-Cancer Early Detection Program

Multi-Cancer Early Detection Program

September 1, 2024
With an aim of intercepting cancers in Texans earlier, the program includes approximately 50,000 MCED tests being administered to BSW patients across North Texas.
Learn More Multi-Cancer Early Detection Program